Literature DB >> 17912044

The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.

Thomas E Wooters1, Michael T Bardo.   

Abstract

In addition to delivering nicotine, tobacco smoke also inhibits monoamine oxidase (MAO). Although MAO inhibitors (MAOIs) can increase nicotine self-administration in rodents, the effects of MAOIs on the discriminative stimulus effect of nicotine are not known. This study examined the effects of three MAOIs (phenelzine, clorgyline and pargyline) with varying selectivity for MAOA and MAOB in the nicotine drug discrimination procedure in rats. Adult male Sprague-Dawley rats were trained to discriminate nicotine (0.3 mg/kg, subcutaneously) from saline in a standard, two-lever food-reinforced operant task. Once the discrimination was acquired, the ability of each MAOI to substitute for or alter the discriminative stimulus effect of nicotine was determined. In substitution tests, nicotine (0.03-0.3 mg/kg) produced full, dose-dependent substitution. Although the selective MAOA inhibitor clorgyline (3-56 mg/kg) and the selective MAOB inhibitor pargyline (3-56 mg/kg) did not elicit any nicotine-appropriate responding, partial substitution was obtained with the nonselective MAO inhibitor phenelzine (1-17 mg/kg). Phenelzine (10 mg/kg) also enhanced the discriminative stimulus effect of a low dose of nicotine (0.056 mg/kg) and prolonged the time course effect of the nicotine-training dose. These findings indicate that concomitant inhibition of MAOA and MAOB can enhance the discriminative stimulus effect of nicotine in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912044     DOI: 10.1097/FBP.0b013e3282eff0d5

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  11 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 2.  Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Jacqueline R Kulbe; Edward D Hall
Journal:  Exp Neurol       Date:  2020-04-20       Impact factor: 5.330

Review 3.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

4.  Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science.

Authors:  Mark G LeSage; John R Smethells; Andrew C Harris
Journal:  Behav Anal (Wash D C)       Date:  2018-07-09

5.  The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.

Authors:  Shahrdad Lotfipour; Monica M Arnold; Derk J Hogenkamp; Kelvin W Gee; James D Belluzzi; Frances M Leslie
Journal:  Neuropharmacology       Date:  2011-03-23       Impact factor: 5.250

6.  A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch.

Authors:  Ivan Berlin; Ian M Hunneyball; Doris Greiling; Stephen P Jones; Hermann Fuder; Hans-Detlev Stahl
Journal:  Psychopharmacology (Berl)       Date:  2012-03-27       Impact factor: 4.530

7.  The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.

Authors:  Joshua S Beckmann; Kiran B Siripurapu; Justin R Nickell; David B Horton; Emily D Denehy; Ashish Vartak; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  J Pharmacol Exp Ther       Date:  2010-08-30       Impact factor: 4.030

8.  MAOA methylation is associated with nicotine and alcohol dependence in women.

Authors:  Robert A Philibert; Tracy D Gunter; Steven R H Beach; Gene H Brody; Anup Madan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-07-05       Impact factor: 3.568

9.  A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.

Authors:  Andrea H Weinberger; Erin L Reutenauer; Peter I Jatlow; Stephanie S O'Malley; Marc N Potenza; Tony P George
Journal:  Drug Alcohol Depend       Date:  2009-11-24       Impact factor: 4.492

10.  MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.

Authors:  Yi-Cheng Lin; Yi-Ting Chang; Mel Campbell; Tzu-Ping Lin; Chin-Chen Pan; Hsin-Chen Lee; Jean C Shih; Pei-Ching Chang
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.